Greenleaf Trust’s Cognizant CTSH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-5,818
| Closed | -$357K | – | 879 |
|
|
2026
Q1 | $357K | Sell |
5,818
-653
| -10% | -$46.7K | ﹤0.01% | 590 |
|
|
2025
Q4 | $537K | Buy |
6,471
+81
| +1% | +$6.06K | ﹤0.01% | 481 |
|
|
2025
Q3 | $429K | Sell |
6,390
-1,320
| -17% | -$95.4K | ﹤0.01% | 536 |
|
|
2025
Q2 | $602K | Buy |
7,710
+255
| +3% | +$19.5K | 0.01% | 445 |
|
|
2025
Q1 | $570K | Buy |
7,455
+933
| +14% | +$76K | 0.01% | 464 |
|
|
2024
Q4 | $502K | Buy |
6,522
+196
| +3% | +$15.3K | ﹤0.01% | 503 |
|
|
2024
Q3 | $488K | Buy |
6,326
+296
| +5% | +$22.1K | ﹤0.01% | 522 |
|
|
2024
Q2 | $410K | Sell |
6,030
-3
| -0% | -$203 | ﹤0.01% | 527 |
|
|
2024
Q1 | $442K | Buy |
6,033
+276
| +5% | +$21.1K | ﹤0.01% | 507 |
|
|
2023
Q4 | $435K | Buy |
5,757
+896
| +18% | +$61.9K | ﹤0.01% | 499 |
|
|
2023
Q3 | $329K | Sell |
4,861
-72
| -1% | -$4.97K | ﹤0.01% | 555 |
|
|
2023
Q2 | $322K | Sell |
4,933
-2,024
| -29% | -$125K | ﹤0.01% | 576 |
|
|
2023
Q1 | $424K | Buy |
6,957
+942
| +16% | +$59K | ﹤0.01% | 497 |
|
|
2022
Q4 | $344K | Sell |
6,015
-1,121
| -16% | -$65.7K | ﹤0.01% | 549 |
|
|
2022
Q3 | $410K | Sell |
7,136
-354
| -5% | -$23.2K | 0.01% | 446 |
|
|
2022
Q2 | $506K | Sell |
7,490
-1,584
| -17% | -$121K | 0.01% | 389 |
|
|
2022
Q1 | $814K | Buy |
9,074
+1,992
| +28% | +$175K | 0.01% | 287 |
|
|
2021
Q4 | $628K | Buy |
7,082
+1,476
| +26% | +$119K | 0.01% | 352 |
|
|
2021
Q3 | $416K | Buy |
5,606
+424
| +8% | +$31.3K | 0.01% | 457 |
|
|
2021
Q2 | $359K | Sell |
5,182
-96
| -2% | -$7.15K | ﹤0.01% | 502 |
|
|
2021
Q1 | $412K | Buy |
5,278
+1,583
| +43% | +$122K | 0.01% | 436 |
|
|
2020
Q4 | $303K | Buy |
3,695
+326
| +10% | +$24.8K | ﹤0.01% | 449 |
|
|
2020
Q3 | $234K | Buy |
+3,369
| New | +$219K | ﹤0.01% | 475 |
|
|
2020
Q2 | – | Sell |
-86,537
| Closed | -$4.02M | – | 563 |
|
|
2020
Q1 | $4.02M | Sell |
86,537
-2,871
| -3% | -$171K | 0.08% | 51 |
|
|
2019
Q4 | $5.54M | Sell |
89,408
-5,394
| -6% | -$333K | 0.09% | 57 |
|
|
2019
Q3 | $5.71M | Sell |
94,802
-33,517
| -26% | -$2.12M | 0.09% | 51 |
|
|
2019
Q2 | $8.13M | Buy |
128,319
+5,520
| +4% | +$362K | 0.13% | 43 |
|
|
2019
Q1 | $8.9M | Buy |
122,799
+1,210
| +1% | +$84.7K | 0.15% | 38 |
|
|
2018
Q4 | $7.72M | Sell |
121,589
-436
| -0.4% | -$30.3K | 0.15% | 37 |
|
|
2018
Q3 | $9.41M | Buy |
122,025
+2,157
| +2% | +$169K | 0.17% | 30 |
|
|
2018
Q2 | $9.47M | Buy |
119,868
+4,224
| +4% | +$332K | 0.18% | 22 |
|
|
2018
Q1 | $9.31M | Buy |
115,644
+2,300
| +2% | +$182K | 0.18% | 23 |
|
|
2017
Q4 | $8.05M | Buy |
113,344
+10,476
| +10% | +$766K | 0.16% | 32 |
|
|
2017
Q3 | $7.46M | Sell |
102,868
-7,511
| -7% | -$528K | 0.16% | 34 |
|
|
2017
Q2 | $7.33M | Sell |
110,379
-5,753
| -5% | -$366K | 0.17% | 33 |
|
|
2017
Q1 | $6.91M | Sell |
116,132
-9,576
| -8% | -$551K | 0.17% | 36 |
|
|
2016
Q4 | $7.04M | Sell |
125,708
-2,102
| -2% | -$112K | 0.18% | 39 |
|
|
2016
Q3 | $6.1M | Buy |
127,810
+12,877
| +11% | +$733K | 0.16% | 44 |
|
|
2016
Q2 | $6.58M | Buy |
114,933
+9,426
| +9% | +$570K | 0.17% | 42 |
|
|
2016
Q1 | $6.62M | Buy |
+105,507
| New | +$6.13M | 0.18% | 44 |
|
Other funds holding CTSH
ECSS
VF
YIH
AIM
AAIS
AS
Greenleaf Trust's CTSH Position: Q2 2026 in Review
Greenleaf Trust sold out of Cognizant (CTSH) in Q2 2026, closing a stake of 5,818 shares — an estimated $357K sold.
Greenleaf Trust first reported a position in CTSH in Q1 2016 and held it in 40 quarters. The position peaked at $9.47M in Q2 2018. 286 funds tracked by Wall St. Rank hold CTSH as of Q2 2026.
- Greenleaf Trust reported no remaining Cognizant position as of Q2 2026 after selling out during the quarter.
- Greenleaf Trust sold 5,818 Cognizant shares in Q2 2026, an estimated $357K.
- Greenleaf Trust first reported a position in Cognizant in Q1 2016 and held it in 40 quarters.
- Greenleaf Trust's Cognizant position peaked at $9.47M in Q2 2018.
- 286 funds tracked by Wall St. Rank held Cognizant as of Q2 2026.
Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.